Statements (60)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:physicist
|
gptkbp:bfsLayer |
5
|
gptkbp:bfsParent |
gptkb:The_Voyage_of_the_Jerle_Shannara
|
gptkbp:caused_by |
gptkb:Bacillus_anthracis
|
gptkbp:characteristics |
produces toxins
aerobic organism forms spores gram-positive bacterium |
gptkbp:conservation_status |
resistant to heat and desiccation
can survive in soil for decades |
gptkbp:distribution |
worldwide
|
gptkbp:duration |
10 days for cutaneous anthrax
60 days for inhalation anthrax 60 days for post-exposure prophylaxis |
gptkbp:end_of_life |
high if untreated
low with early treatment |
gptkbp:first_described_by |
ancient times
by Robert Koch in 1876 |
gptkbp:formed |
can remain dormant for years
can survive in harsh conditions |
gptkbp:healthcare |
gptkb:zoo
potential bioterrorism agent |
gptkbp:historical_significance |
gptkb:biological_warfare
gptkb:2001_anthrax_attacks_in_the_US |
https://www.w3.org/2000/01/rdf-schema#label |
Antrax
|
gptkbp:incubation_period |
1 to 7 days
|
gptkbp:is_protected_by |
vaccination
|
gptkbp:is_vulnerable_to |
gptkb:Anthrax_vaccine_adsorbed_(AVA)
gptkb:Bio_Thrax |
gptkbp:risk_factor |
exposure to contaminated soil
working with animal products |
gptkbp:social_responsibility |
blood tests
chest X-ray skin examination PCR testing culture of the bacteria |
gptkbp:symptoms |
fatigue
headache nausea cough fever sore throat vomiting chest pain diarrhea sepsis shock shortness of breath muscle aches chest discomfort swelling at the site of infection |
gptkbp:transmission |
contact with infected animals
|
gptkbp:treatment |
antibiotics
supportive care antitoxins intravenous antibiotics for severe cases |
gptkbp:type_of |
gptkb:cutaneous_anthrax
gptkb:inhalation_anthrax gptkb:injection_anthrax gastrointestinal anthrax |